- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Congenital thrombotic thrombocytopenic purpura (cTTP)
- Meeting Date: July 2026
Apadamtase alfa with cinaxadamtase alfa (recombinant adamts13) – July 2026
- Powder for injection 500 I.U. with solvent
- Powder for injection 1500 I.U. with solvent
Public Summary Documents
Last updated
13 November 2026
